Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8

Preclinical studies on gene delivery into mouse lymphocytes are often hampered by insufficient activity of lentiviral (LV) and adeno-associated vectors (AAVs) as well as missing tools for cell type selectivity when considering in vivo gene therapy. Here, we selected designed ankyrin repeat proteins...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Michels, Alexander (VerfasserIn) , Frank, Annika M. (VerfasserIn) , Günther, Dorothee M. (VerfasserIn) , Mataei, Mehryad (VerfasserIn) , Börner, Kathleen (VerfasserIn) , Grimm, Dirk (VerfasserIn) , Hartmann, Jessica (VerfasserIn) , Buchholz, Christian J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 October 2021
In: Molecular therapy. Methods & clinical development
Year: 2021, Jahrgang: 23, Pages: 334-347
ISSN:2329-0501
DOI:10.1016/j.omtm.2021.09.014
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.omtm.2021.09.014
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2329050121001522
Volltext
Verfasserangaben:Alexander Michels, Annika M. Frank, Dorothee M. Günther, Mehryad Mataei, Kathleen Börner, Dirk Grimm, Jessica Hartmann, and Christian J. Buchholz

MARC

LEADER 00000caa a2200000 c 4500
001 179603245X
003 DE-627
005 20240416193219.0
007 cr uuu---uuuuu
008 220318s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.omtm.2021.09.014  |2 doi 
035 |a (DE-627)179603245X 
035 |a (DE-599)KXP179603245X 
035 |a (OCoLC)1341446248 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Michels, Alexander  |e VerfasserIn  |0 (DE-588)1254550968  |0 (DE-627)1797025414  |4 aut 
245 1 0 |a Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8  |c Alexander Michels, Annika M. Frank, Dorothee M. Günther, Mehryad Mataei, Kathleen Börner, Dirk Grimm, Jessica Hartmann, and Christian J. Buchholz 
246 3 0 |a eight 
264 1 |c 1 October 2021 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.03.2022 
520 |a Preclinical studies on gene delivery into mouse lymphocytes are often hampered by insufficient activity of lentiviral (LV) and adeno-associated vectors (AAVs) as well as missing tools for cell type selectivity when considering in vivo gene therapy. Here, we selected designed ankyrin repeat proteins (DARPins) binding to murine CD8. The top-performing DARPin was displayed as targeting ligand on both vector systems. When used on engineered measles virus (MV) glycoproteins, the resulting mCD8-LV transduced CD8+ mouse lymphocytes with near-absolute (>99%) selectivity. Despite its lower functional titer, mCD8-LV achieved 4-fold higher gene delivery to CD8+ cells than conventional VSV-LV when added to whole mouse blood. Addition of mCD8-LV encoding a chimeric antigen receptor (CAR) specific for mouse CD19 to splenocytes resulted in elimination of B lymphocytes and lymphoma cells. For display on AAV, the DARPin was inserted into the GH2-GH3 loop of the AAV2 capsid protein VP1, resulting in a DARPin-targeted AAV we termed DART-AAV. Stocks of mCD8-AAV contained similar genome copies as AAV2 but were >20-fold more active in gene delivery in mouse splenocytes, while exhibiting >99% specificity for CD8+ cells. These results suggest that receptor targeting can overcome blocks in transduction of mouse splenocytes. 
650 4 |a AAV capsid engineering 
650 4 |a cancer immunotherapy 
650 4 |a CAR 
650 4 |a chimeric antigen receptor 
650 4 |a gene therapy 
650 4 |a splenocytes 
650 4 |a viral vectors 
700 1 |a Frank, Annika M.  |e VerfasserIn  |4 aut 
700 1 |a Günther, Dorothee M.  |e VerfasserIn  |4 aut 
700 1 |a Mataei, Mehryad  |e VerfasserIn  |4 aut 
700 1 |a Börner, Kathleen  |e VerfasserIn  |0 (DE-588)1030276382  |0 (DE-627)734977727  |0 (DE-576)378068806  |4 aut 
700 1 |a Grimm, Dirk  |e VerfasserIn  |0 (DE-588)1016476671  |0 (DE-627)70553376X  |0 (DE-576)352260645  |4 aut 
700 1 |a Hartmann, Jessica  |e VerfasserIn  |4 aut 
700 1 |a Buchholz, Christian J.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy. Methods & clinical development  |d New York, NY : Nature Publishing Group, 2014  |g 23(2021) vom: Dez., Seite 334-347  |h Online-Ressource  |w (DE-627)863823203  |w (DE-600)2863173-0  |w (DE-576)475381483  |x 2329-0501  |7 nnas  |a Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8 
773 1 8 |g volume:23  |g year:2021  |g month:12  |g pages:334-347  |g extent:14  |a Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8 
856 4 0 |u https://doi.org/10.1016/j.omtm.2021.09.014  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2329050121001522  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220318 
993 |a Article 
994 |a 2021 
998 |g 1016476671  |a Grimm, Dirk  |m 1016476671:Grimm, Dirk  |d 910000  |d 911700  |e 910000PG1016476671  |e 911700PG1016476671  |k 0/910000/  |k 1/910000/911700/  |p 6 
998 |g 1030276382  |a Börner, Kathleen  |m 1030276382:Börner, Kathleen  |d 910000  |d 911700  |e 910000PB1030276382  |e 911700PB1030276382  |k 0/910000/  |k 1/910000/911700/  |p 5 
999 |a KXP-PPN179603245X  |e 4095194685 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 30.03.2022"],"person":[{"role":"aut","display":"Michels, Alexander","given":"Alexander","roleDisplay":"VerfasserIn","family":"Michels"},{"roleDisplay":"VerfasserIn","family":"Frank","display":"Frank, Annika M.","role":"aut","given":"Annika M."},{"role":"aut","display":"Günther, Dorothee M.","given":"Dorothee M.","family":"Günther","roleDisplay":"VerfasserIn"},{"family":"Mataei","roleDisplay":"VerfasserIn","display":"Mataei, Mehryad","role":"aut","given":"Mehryad"},{"display":"Börner, Kathleen","role":"aut","given":"Kathleen","roleDisplay":"VerfasserIn","family":"Börner"},{"family":"Grimm","roleDisplay":"VerfasserIn","display":"Grimm, Dirk","role":"aut","given":"Dirk"},{"role":"aut","display":"Hartmann, Jessica","given":"Jessica","family":"Hartmann","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Buchholz, Christian J.","given":"Christian J.","family":"Buchholz","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"14 S."}],"id":{"doi":["10.1016/j.omtm.2021.09.014"],"eki":["179603245X"]},"relHost":[{"part":{"pages":"334-347","text":"23(2021) vom: Dez., Seite 334-347","volume":"23","year":"2021","extent":"14"},"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"pubHistory":["1 (08. Jan. 2014)-"],"recId":"863823203","disp":"Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8Molecular therapy. Methods & clinical development","title":[{"title_sort":"Molecular therapy","partname":"Methods & clinical development","title":"Molecular therapy"}],"origin":[{"publisherPlace":"New York, NY","dateIssuedDisp":"[2014]-","publisher":"Nature Publishing Group"}],"titleAlt":[{"title":"Methods and clinical development"}],"id":{"zdb":["2863173-0"],"eki":["863823203"],"issn":["2329-0501"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 25.06.20"]}],"origin":[{"dateIssuedDisp":"1 October 2021","dateIssuedKey":"2021"}],"title":[{"title_sort":"Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8","title":"Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8"}],"recId":"179603245X","type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"name":{"displayForm":["Alexander Michels, Annika M. Frank, Dorothee M. Günther, Mehryad Mataei, Kathleen Börner, Dirk Grimm, Jessica Hartmann, and Christian J. Buchholz"]}} 
SRT |a MICHELSALELENTIVIRAL1202